TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
INO

Inovio Pharmaceuticals Inc

Healthcare · Biotechnology

1.30$ +4.0% vs. previous close Closing price · As of: Sep 22, 2026

Statements

Cash Flow

Inovio Pharmaceuticals Inc (INO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -89 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow INO
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-30 -12 -63 -63 -74 -98 -178 -216 -216 -124 -104 -89
1.6 1.9 3.1 3.5 5.0 5.5 4.6 4.7 5.5 3.5 3.1 3.0
5.4 6.2 10 13 11 11 16 26 23 11 6.6 3.8
6.2 5.6 9.5 16 10 17 96 27 30
2.2 14 -0.5 2.9 4.7 -3.5 -71 50 20 -10 -2.7 -9.2
1.4 2.8 3.9 10 2.1 1.0 1.5 1.2 1.0 0.3 0.5 0.3
-36 -55 16 -28 42 -9.0 -59 -175 110 87 104 14
0.0 0.0 0.0 0.0 93 3.9
59 85 4,300,000 94 -0.6 -0.9 -4.0 -4.6 -1.4
97 97 97 94 0.2 0.0 0.0 0.0 -16 0.0
72 84 7.8 96 31 105 465 211 82 5.0 51 53
6.8 17 -38 4.7 -0.1 -1.5 229 -180 -25 -32 52 -22
-31 -15 -66 -74 -76 -99 -179 -217 -217 -125 -105 -89

Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?